These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19046477)

  • 1. Cancer and immune-mediated disease in people who have had meningococcal disease: record-linkage studies.
    Goldacre MJ; Wotton CJ; Yeates DG
    Epidemiol Infect; 2009 May; 137(5):681-7. PubMed ID: 19046477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between infectious mononucleosis and cancer: record-linkage studies.
    Goldacre MJ; Wotton CJ; Yeates DG
    Epidemiol Infect; 2009 May; 137(5):672-80. PubMed ID: 18840316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses.
    Wotton CJ; Goldacre MJ
    J Epidemiol Community Health; 2012 Dec; 66(12):1177-81. PubMed ID: 22493476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancers and immune related diseases associated with Down's syndrome: a record linkage study.
    Goldacre MJ; Wotton CJ; Seagroatt V; Yeates D
    Arch Dis Child; 2004 Nov; 89(11):1014-7. PubMed ID: 15499053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor necrosis factor polymorphism TNF (-308) is associated with susceptibility to meningococcal sepsis, but not with lethality.
    Read RC; Teare DM; Pridmore AC; Naylor SC; Timms JM; Kaczmarski EB; Borrow R; Wilson AG
    Crit Care Med; 2009 Apr; 37(4):1237-43. PubMed ID: 19242354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for invasive meningococcal disease in southern Queensland, 2000-2001.
    McCall BJ; Neill AS; Young MM
    Intern Med J; 2004 Aug; 34(8):464-8. PubMed ID: 15317544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphism of the binding domain of surfactant protein-A2 increases susceptibility to meningococcal disease.
    Jack DL; Cole J; Naylor SC; Borrow R; Kaczmarski EB; Klein NJ; Read RC
    Clin Infect Dis; 2006 Dec; 43(11):1426-33. PubMed ID: 17083016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization.
    Weng X; Liu L; Barcellos LF; Allison JE; Herrinton LJ
    Am J Gastroenterol; 2007 Jul; 102(7):1429-35. PubMed ID: 17437504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underestimation of invasive meningococcal disease case fatality rates.
    Crépey P; Getsios D
    Clin Infect Dis; 2009 Oct; 49(7):1136-7; author reply 1137. PubMed ID: 19739964
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of association between group B meningococcal disease and autoimmune disease.
    Howitz M; Krause TG; Simonsen JB; Hoffmann S; Frisch M; Nielsen NM; Robbins J; Schneerson R; Mølbak K; Miller MA
    Clin Infect Dis; 2007 Nov; 45(10):1327-34. PubMed ID: 17968829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of meningococcal disease associated with genomic bacterial load.
    Darton T; Guiver M; Naylor S; Jack DL; Kaczmarski EB; Borrow R; Read RC
    Clin Infect Dis; 2009 Mar; 48(5):587-94. PubMed ID: 19191644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential risks of cancer types in people with Parkinson's disease: a national record-linkage study.
    Ong EL; Goldacre R; Goldacre M
    Eur J Cancer; 2014 Sep; 50(14):2456-62. PubMed ID: 25065294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographic and socioeconomic variation in meningococcal disease: a rural/urban comparison.
    Olowokure B; Onions H; Patel D; Hooson J; O'Neill P
    J Infect; 2006 Jan; 52(1):61-6. PubMed ID: 16368462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal disease in Arkansas.
    J Ark Med Soc; 1997 Apr; 93(11):558-9. PubMed ID: 9114649
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in cancer incidence patterns among a northeastern American Indian population: 1955-1969 versus 1990-2004.
    Mahoney MC; Va P; Stevens A; Kahn AR; Michalek AM
    J Rural Health; 2009; 25(4):378-83. PubMed ID: 19780918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal disease in Ontario during the winter of 1988-1989.
    Heimann GA; Mikel DE; Naus M; Goel V; Tischler M; Carlson JA; Schabas R; Pasut G; Borczyk A; Krishnan C
    Can Dis Wkly Rep; 1989 Mar; 15(11):59-62. PubMed ID: 2713946
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on meningococcal disease mortality in the United States since 2002.
    Kim GY; Sorvillo F; Kuo T
    Pediatr Infect Dis J; 2010 Jul; 29(7):681. PubMed ID: 20574406
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.
    Bettinger JA; Scheifele DW; Le Saux N; Halperin SA; Vaudry W; Tsang R;
    Pediatr Infect Dis J; 2009 Mar; 28(3):220-4. PubMed ID: 19209096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal infections in England and Wales: 1992.
    Jones DM; Kaczmarski EB
    Commun Dis Rep CDR Rev; 1993 Aug; 3(9):R129-31. PubMed ID: 7693173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.